Endpoint provides clients with high-quality, authoritative advice on the clinical development of medicines.
Endpoint's clients include multinational pharmaceutical companies, emerging biomedical ventures, biotechnology investment firms, contract research organizations, regulatory agencies and national health services.
 
Endpoint has offices in Seattle and London.